PURPOSE Recognizing primary human immunodefi ciency virus (HIV) infection is important for public health. The prevalence in outpatient settings is largely unknown but would be useful in developing testing guidelines. The objective of this study is to estimate the national prevalence of primary HIV infection in symptomatic ambulatory patients regardless of risk factors.
INTRODUCTION
N inety percent of the estimated 40,000 new HIV infections in the United States each year are associated with the acute HIV syndrome. 1, 2 One to 4 weeks after infection, patients with the acute HIV syndrome experience symptoms of a viral illness, such as fever, fatigue, pharyngitis, myalgias, rash, and weight loss, as well as other nonspecifi c symptoms. [1] [2] [3] [4] [5] Most of these patients seek medical care, but seldom do they have primary HIV infection diagnosed. 1, 2, 6 The diagnosis of primary HIV infection has important clinical and public health implications. Patients who do not have their condition diagnosed at this early stage of infection will often seek care much later for acquired immunodefi ciency syndrome (AIDS), when treatment may not be as effective. 7 Diagnosis of primary HIV infection represents an important opportunity to prevent transmission to others, because in the early stages of the disease, patients have high levels of viremia, which, coupled with a lack of awareness of their diagnosis, can lead to transmission through sexual activity. 8, 9 The prevalence of primary HIV infection in patients visiting outpatient facilities in the United States is largely unknown. One recent prospective PREVALENCE OF PRIMARY HIV INFECTION study determined a prevalence of 1% for patients with viral symptoms and at least 1 risk factor seeking care at an urban urgent care center, a setting in which a high prevalence of HIV infection is expected. 10 Other studies have concluded that no symptom is suffi ciently sensitive and specifi c to allow for targeted testing. 4, 5 It is diffi cult to determine which persons have a substantial probability of primary HIV infection when evaluating risk factors alone. 11 Furthermore, patients may not be aware of their risky behavior. 12 An estimate of the national prevalence of primary HIV infection in patients seeking care at ambulatory settings, regardless of risk factors, would be important for clinical care in developing testing guidelines. Our objective for this study was to calculate a national estimate of the prevalence of primary HIV infection for patients visiting physician' s offi ces, emergency departments, and hospital outpatient clinics with symptoms consistent with primary HIV infection regardless of risk factors.
METHODS
This study is an analysis of the 2000 National Ambulatory Medical Care Survey (NAMCS) and the 2000 National Hospital Ambulatory Medical Survey (NHAMCS) to identify ambulatory patients with symptoms and diagnoses consistent with primary HIV infection to develop a denominator for a national ambulatory prevalence estimate. The numerator for the prevalence was derived from the Centers for Disease Control and Prevention (CDC) estimate of annual new cases of HIV infection and modifi ed by reports in the medical literature regarding the percentage of patients newly infected with HIV who have specifi c symptoms, as well the percentage that seek medical care during the phase of acute infection.
Target Population
The target population is US patients with symptoms of primary HIV infection seeking care at physician offi ces, hospital emergency departments, and hospital outpatient clinics. This population is represented in the 2000 NAMCS and 2000 NHAMCS. These surveys are national probability samples of nonfederal offi ce-based physicians, hospital emergency departments, and hospital outpatient departments. 13, 14 The NAMCS includes only visits to physician offi ces. The NHAMCS includes 2 separate databases: 1 for emergency departments and 1 for hospital outpatient clinics. Both surveys are conducted annually by the National Centers for Health Statistics and use a multistage probability sample design that is stratifi ed and weighted to allow for population estimates of annual visits. Selected entities complete a survey form for visits during a randomly selected 1-week period. Combined, the surveys represent about 90% of US ambulatory visits with the exception of federal, veterans, and military outpatient facilities. The analysis is restricted to patients aged 13 through 54 years, inclusive, as they account for 95.2% of new HIV cases based on surveillance data from 25 states.
15
Prevalence Estimate: Denominator A list of 17 symptoms consistent with primary HIV infection was generated from 3 US studies by including any symptom reported by more than 25% of patients with a diagnosis of primary HIV infection (Table 1) . 2, 4, 5 Both the NAMCS and NAMHCS include variables for up to 3 reasons for the visit. The NAMCS and the hospital outpatient clinic fi le in the NHAMCS contain a variable that allows for designation of acute visits. Emergency department visits in the NHAMCS are assumed to be for acute problems. The databases were analyzed separately for each of the 17 primary HIV infection symptoms listed in Table 1 to generate the total number of annual patients with an acute problem and each symptom as 1 of the 3 reasons for their visit. The total number of patients reporting each symptom was refi ned to include only those for whom the other 2 of their top 3 Note: Symptoms reported by more than 25% of patients in Schacker et al, 2 Hecht et al, 4 and Daar et al. 5 HIV = human immunodefi ciency virus; NAMCS = National Ambulatory Medical Care Survey; NHAMCS = National Hospital Ambulatory Medical Care Survey.
symptoms were also consistent with primary HIV infection. For example, patients reporting fever as their fi rst reason for the visit would be included in the estimate for that symptom if their second and third reasons for the visit were fatigue or pharyngitis or other symptoms consistent with primary HIV infection as listed in Table  1 . Whereas, if fever was their second or third reason for the visit, then the fi rst and third or fi rst and second other 2 reasons for the visit would need to be for symptoms consistent with primary HIV infection. A few other visit reasons not listed in Table 1 but considered consistent with a viral illness were also considered inclusion variables. These were enlarged glands, diffi culty swallowing (as a symptom of throat pain), and unspecifi ed pain. NAMCS and NHAMCS contain data for up to 3 diagnoses for each visit. Primary diagnoses, but not secondary or tertiary ones, considered inconsistent with any of the constellation of primary HIV infection symptoms in Table 1 were excluded to further defi ne the estimate.
The data were analyzed with the Statistical Export and Tabulation System (SETS 2.0), US National Center for Health Statistics. Relative standard errors, the measure of the sampling variability that occurs by chance, were calculated based on National Center for Health Statistics' coeffi cients and formulas as reported in the NAMCS and NHAMCS.
Prevalence Estimate: Numerator
The numerator for disease prevalence was derived from the CDC estimate of the annual number of new HIV infections of 40,000 per year. 16, 17 In addition to the 13-to 54-year age restrictions (95.2% of new HIV diagnoses), this number was further decreased by 3 other factors. First, the 40,000 new HIV infections estimate was reduced by 10%, because the NAMCS and NHAMCS represent only 90% of US annual ambulatory visits. Second, an estimate of the percentage of patients with primary HIV infection reporting each symptom was derived from 127 patients who had primary HIV infection diagnosed from 3 US studies.
2,4,5 Percentage estimates were calculated from all patients with primary HIV infection, regardless of whether acute HIV syndrome was reported, and included 95% confi dence intervals. Third, the numerator estimate needed to be decreased by the percentage of patients with primary HIV infection who sought medical treatment. Only 2 studies, both of predominately urban gay men, reported fi ndings for patients with primary HIV infection symptoms who were seeking care.
1,2 Both studies reported rates close to 90%. Our analysis used the lower rate of 50% because of limited data on care-seeking rates for patients from other segments of the population, such as persons of low socioeconomic status, who may be less likely to seek medical care.
RESULTS

Prevalence Denominator Estimates
The annual number of patients with symptoms of fever, rash, and pharyngitis, as well as other symptoms and diagnoses consistent with primary HIV infection symptoms, is displayed in Supplemental Tables 1, 2 , and 3 (available online only at http://www.annfammed. org/cgi/content/full/3/5/400/DC1). Data detailing exclusionary diagnoses and symptoms in the 3 practice settings represented by NAMCS and NHAMCS are available from the authors. The analysis of the other 14 symptoms from Table 1 showed an inadequate number of patient visits to allow for accurate annual estimates. The combined total number of patient visits for fever and other primary HIV infection symptoms and diagnoses consistent with an acute viral illness from these 3 settings was 2,175,551; there were 6,415,111 such patient visits for pharyngitis and 1,344,060 visits for patients with a rash.
The analysis provided data on which diagnoses were most likely to cause patients to report primary HIV infection symptoms. For example, 46% of patients visiting physician' s offi ces with complaints of fever and other primary HIV infection symptoms had streptococcal sore throat, acute pharyngitis, or infl uenza diagnosed, whereas in the emergency department unspecifi ed viral infection, acute pharyngitis, and pyrexia of unknown origin accounted for 55% of the annual qualifi ed visits. In the hospital clinic population, 75% of qualifi ed visits were for unspecifi ed upper respiratory tract infections, acute pharyngitis, and streptococcal sore throat.
Prevalence Numerator Estimates
Estimates for the annual number of patients aged 13 to 54 years with primary HIV infection seeking care in physician offi ces, emergency departments, and hospital clinics with complaints of fever, rash, or pharyngitis are listed in Supplemental Table 4 (available online only at http://www.annfammed.org/cgi/content/ full/3/5/400/DC1). An estimated combined total of 14,394 patients newly infected with HIV who had fever, 8,568 who had pharyngitis, and 7,540 who had rash were seen in these 3 settings in 2000.
Prevalence Estimates
The prevalence estimates for patients aged 13 to 54 years with symptoms of fever, rash, and pharyngitis, as well as other symptoms and diagnoses consistent with primary HIV infection, are displayed in Table 2 . Patients with fever had the highest rate of primary HIV infection, 0.66% or 6.6 cases per 1,000; the rate for those with rash was 0.56%, or 5.6 cases per 1,000; and for those with pharyngitis the rate was 0.13%, or 1.3 cases per 1,000. Prevalence estimates include a range
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of values based on the relative standard error of the denominator estimate and the 95% confi dence interval for the numerator estimate.
Sensitivity Analysis
Sensitivity analysis involves recalculating results when assumptions about variable estimates are altered because of uncertainty. In this analysis the most uncertain estimate was the percentage of patients with primary HIV infection who sought care. The baseline analysis assumed that 50% of patients with primary HIV infection would seek medical care. Data are lacking, however, outside the urban, gay, male populations, for which the rate is 90%. 1, 2 If this assumption were varied from 25% to 90%, then for patients with fever the prevalence would vary from 0.33% to 1.19%; for rash from 0.28% to 1.01%; and for sore throat from 0.07% to 0.23%.
DISCUSSION
This analysis provides an initial estimate of the national prevalence of primary HIV infection in patients visiting ambulatory settings with complaints of fever, rash, or sore throat and a diagnosis consistent with an acute viral illness. A national prevalence estimate of primary HIV infection provides a useful starting point for policy decisions regarding early detection and referral programs, as emphasized in a recent CDC initiative. 18 For instance, although current counseling, testing, and referral guidelines recommend routine HIV testing in populations with a prevalence of 1%, 19 a more recent cost-effectiveness analysis has shown that in the era of highly active antiretroviral treatment, testing may be cost-effective when the prevalence is as low as 0.05%, 20 ie, rates lower than those found in this study for patients with fever or rash or pharyngitis. The only previous study to develop a prevalence estimate was a prospective study of 499 patients visiting an urban urgent care center in Boston. 10 The prevalence was 1%
for patients complaining of viral symptoms who had at least 1 risk factor for HIV. The prevalence in that population would be expected to be higher than a national estimate based on patients from all settings with similar symptoms regardless of risk factors and thus corroborates these results. This study has several limitations because of assumptions made in the analysis. The most uncertain estimate involves the percentage of patients that actually seek medical care during the symptomatic phase of primary HIV infection. Although the baseline assumption of 50% is reasonable because patients with primary HIV infection are ill for 10 to 14 days, and previous reports of care-seeking behavior are 90% for urban gay males, the true percentage is largely unknown. [1] [2] [3] [4] [5] Poor, disenfranchised, injection drug users who acquire HIV infection through needle-sharing behavior, for instance, may be less likely to seek care because they lack insurance or transportation. This issue was addressed through a sensitivity analysis that lowered the rate of those seeking care to 25%, more one third less than that reported in the literature.
Several factors could have affected the denominator estimate. Excluding primary diagnoses that included a patient presenting with primary HIV infection symptoms could decrease the denominator and falsely increase the prevalence estimate. To minimize this potential source of error, all diagnoses possibly construed as viral (Supplemental Tables 1, 2 and 3 (available online only at http://www.annfammed. org/cgi/content/full/3/5/400/DC1) were included in the denominator. Additionally, other diagnoses unlikely to represent viral infections but not entirely inconsistent with primary HIV infection symptoms, such as tension headache, migraine headache, unspecifi ed abdominal pain, and gastroesophageal refl ux, were included as well.
Another factor that could affect the denominator estimate is the restriction of the analysis to primary diagnoses. The analysis was concerned with only acute problems. In line with this study assumption, diagnostic coding guidelines specify that the primary diagnosis should refl ect the patient' s main reason for the visit. It is possible, however, especially in private offi ces with familiar patients, that a chronic problem was coded fi rst even though the patient was seeking care for an acute illness. Missing these visits would decrease the denominator estimate. To assess the impact of this source of potential error, the data were analyzed for visits to physician' s offi ces for patients reporting fever. A total of 17,824 patients, or 1.75% of the 1,017,573 patients included from this data fi le, had secondary or tertiary diagnoses consistent with primary HIV infection. Increasing the denominator estimate by 1.75% would minimally decrease the prevalence for febrile patients from 0.66% to 0.65%.
Last, although an attempt was made to include the correct codes for the primary HIV infection symptoms reported in the literature and their likely synonyms, it is possible that some symptoms were coded for visit reasons not included in the analysis, whereas some of the inclusion symptoms, such as chills and feeling hot as possible synonyms for fever, could have overestimated the denominator estimates.
In conclusion, this study is the fi rst to estimate the national prevalence of primary HIV infection. Prevalence estimates were developed from national ambulatory databases for patients aged 13 to 54 years regardless of risk factors who sought care for fever, rash, or sore throat and had an acute illness consistent with a viral infection. We believe these estimates will be useful in developing national testing guidelines that could ultimately aid in decreasing HIV transmission rates and improving the health of those infected through early entry into medical care. 
